๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
A Study of Mezagitamab in Adults With Late Antibody-Mediated Rejection (AMR) After a Kidney Transplant
NCT07613359Antibody-Mediated Rejection (AMR)
Takeda
Phase 2
36
Beijing, Guangdong, Nanning, Wuhan, Xi'an, Jinan, Chengdu, Hangzhou
2026-09-01
By invitation
Homoharringtonine, Lisaftoclax, and Azacitidine for AML After Venetoclax-Based Therapy Failure
NCT07813390Acute Myeloid Leukemia (AML)
Guangdong Second Provincial General Hospital
Phase 2
73
Guangzhou
2026-09-01
Not yet open
Spatially Fractionated Radiation Therapy for Locally Advanced Cervical Cancer
NCT07781475Cervical Cancer
The University of Hong Kong-Shenzhen Hospital
Not applicable
126
Shenzhen
2026-09-01
Not yet open
Clinical Trials Comparing Trastuzumab Plus Bevacizumab With Bevacizumab as First-line Maintenance Therapy for Epithelial Ovarian Cancer
NCT07779538Ovarian Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3
420
Beijing, Zhejiang, Yunnan
2026-09-01
Recruiting
Glycoprotein IIb/IIIa PET/CT in Various GPIIb/IIIa-Related Disease
NCT07813559Thrombi, Thrombus, Brain, Thrombus
Tianjin Medical University
Observational
500
Hefei, Qingdao, Tianjin
2026-09-01
Not yet open
Human Umbilical Cord Mesenchymal Stem Cell Infusion for Type 2 Diabetic Nephropathy
NCT07769671Diabetic Nephropathy Type 2
The First People's Hospital of Changzhou
Phase 1/2
49
Changzhou
2026-09-01
Not yet open
A Study of ATG-201 in Adult Participants With Autoimmune Diseases
NCT07732309Systemic Lupus Erythematosus, Systemic Sclerosis (SSc), Sjogren's Disease, Autoimmune Diseases
Antengene Biologics Limited
Phase 1
149
Bengbu, Hefei, Beijing, Xiamen, Guangzhou, Luoyang, Zhengzhou, Wuhan
2026-09-01
Not yet open
Dentate-Targeted Temporal Interference Stimulation for Post-Stroke Dysphagia
NCT07766668Deglutition Disorders, Ischemic Stroke
Zhejiang University
Not applicable
88
Hangzhou
2026-09-01
Not yet open
A Comparative Study of Delayed Endoscopic DTI and Latissimus Dorsi ยฑImpalnt Reconstruction Post-Mastectomy
NCT07757074Breast Cancer
Du Zhenggui
Observational
268
Chengdu
2026-09-01
Not yet open
A Prospective Study on the Clinical Value of Skin Test for Oxaliplatin Hypersensitivity Reaction and Its Correlation With Biomarkers
NCT07613905Hypersensitivity Reaction
Fujian Cancer Hospital
Not applicable
380
Fuzhou
2026-09-01
Not yet open
Impact of Propranolol on the Prognosis of Patients With Decompensated Cirrhosis and MELD Score > 9
NCT07652203Cirrhosis
General Hospital of Shenyang Military Region
Not applicable
466
Shenyang
2026-09
Not yet open
A Study of Anti-PD-1 Antibody With or Without BL-B01D1 as Maintenance Therapy Following Anti-PD-1 Antibody Plus Chemotherapy for the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma (PANKU-NPC02)
NCT07783321Nasopharyngeal Carcinoma (NPC)
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3
404
Guangzhou
2026-09
Not yet open
Auricular Acupressure for Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy
NCT07760766Chemotherapy-induced Nausea and Vomiting
China Medical University, China
Not applicable
332
Shenyang
2026-09
Recruiting
Drug-Drug Interaction Study of Vorolanib Tablets in Healthy Participants
NCT07809789DDI (Drug-Drug Interaction)
Betta Pharmaceuticals Co., Ltd.
Phase 1
36
Hangzhou
2026-09
Not yet open
JSKN033 Versus Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Cancer
NCT07797153Recurrent or Metastatic Cervical Cancer
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Phase 3
368
Guangzhou, Shanghai
2026-09
Not yet open
Clinical Trial of TQA3605 Tablet in Combination With Nucleos(t)Ide Analogues(NAs) Versus NAs Alone for the Treatment of Patients With Chronic Hepatitis B Virus Infection Who Have Undergone Treatment and Exhibit Low Viral Load or Poor Response
NCT07797231Chronic Hepatitis B
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3
930
Hefei, Wuhu, Beijing, Chongqing, Fuzhou, Xiamen, Lanzhou, Wuwei
2026-09
Not yet open
SHR-A1811 Monotherapy or Sequential THPy as Neoadjuvant Therapy for Stage II-III HER2-Positive Breast Cancer
NCT07787338HER2-positive Breast Cancer
First Affiliated Hospital of Zhejiang University
Phase 2
80
Hangzhou
2026-09
Not yet open
SNC116 Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
NCT07830238B-cell Acute Lymphoblastic Leukemia
Shanghai Simnova Biotechnology Co.,Ltd.
Phase EARLY_PHASE1
28
Changchun
2026-09
Not yet open
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
NCT07794579Overweight, Prediabetic State, Prehypertension, Obesity, Abdominal
Eli Lilly and Company
Phase 3
2,001
Chengdu, Hefei, Jinan, Luoyang Shi, Nanjing, Ningbo, Qinhuangdao Shi, Tianjin
2026-09
Not yet open
A Study of SI-B036 in Patients With Locally Advanced or Metastatic Gynecological Tumors and Other Solid Tumors
NCT07778862Gynecological Tumors, Solid Tumors
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
30
Wuhan
2026-09
Not yet open
Postoperative ctHPV-DNA for Recurrence Prediction and Adjuvant Treatment Decision-Making in Cervical Cancer
NCT07782697Cervical Cancer, HPV DNA
Anhui Provincial Hospital
Observational
580
Hefei
2026-09
Not yet open
Study on the Mass Balance of [14C] CMS-D002 in Healthy Adult Participants in China
NCT07788482Healthy Volunteers
Shenzhen Kangzhe Biotechnology Co., Ltd.
Phase 1
10
Beijing
2026-09
Not yet open
A Study to Evaluate the Efficacy and Safety of RAG-01 as Monotherapy and in Combination With Chemotherapy in Patients With Non-muscle Invasive Bladder Cancer (NMIBC).
NCT07777848Non-muscle Invasive Bladder Cancer (NMIBC)
Ractigen Therapeutics.
Phase 2
114
Shanghai
2026-09
Not yet open
A Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of HRS-4139 in Healthy Participants
NCT07802964Psoriasis Vulgaris
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 1
40
Changsha
2026-09
Not yet open
A Study of BL-B01D1 With or Without PD-1 Monoclonal Antibody in Patients With High-Risk Locally Advanced Nasopharyngeal Carcinoma
NCT07797881Nasopharyngeal Carcinoma (NPC)
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
60
Guangzhou
2026-09
Not yet open
Context-Guided Personalized iTBS for Depression
NCT07743398Major Depressive Disorder (MDD)
Capital Medical University
Not applicable
60
Beijing
2026-09
Not yet open
A Study of BL-M08D1 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
NCT07788950Head and Neck Squamous Cell Carcinomas, Solid Tumors
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
30
Shanghai
2026-09
Not yet open
A Study of BL-M11D1 in Patients With Relapsed/Refractory Myelodysplastic Syndromes
NCT07591168Myelodysplastic Syndromes
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1/2
92
Tianjin
2026-09
Not yet open
Thiotepa Administration Via Ommaya Reservoir for Leptomeningeal Metastases in Non-Small Cell Lung Cancer Resistant to EGFR-TKI.
NCT07778940Leptomeningeal Metastasis
Tianjin Medical University Cancer Institute and Hospital
Phase 2
50
Tianjin
2026-09
Not yet open
A Study of BL-M08D in Patients With Locally Advanced or Metastatic Digestive Tract Tumors and Other Solid Tumors
NCT07780318Gastrointestinal Tumors, Solid Tumors
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1/2
60
Beijing
2026-09
Not yet open
Sedentary Behavior Intervention for Older Adults With Coronary Heart Disease and Frailty
NCT07762898Coronary Artery Disease, Sedentary Behavior, Prefrailty
Gansu University of Chinese Medicine
Not applicable
64
Lanzhou
2026-09
Recruiting
Real World Study of Icotinib in Adjuvant Post Surgical Treatment for Stage IA2 High Risk to IB EGFR Mutant Non Small Cell Lung Cancer
NCT07806604NSCLC (Non-small Cell Lung Cancer)
Betta Pharmaceuticals Co., Ltd.
Observational
2,572
Beijing, Shanghai
2026-09
Not yet open
SBRT Combined With Reduced-Dose Anthracycline Chemotherapy and Toripalimab as Neoadjuvant Therapy for Localized High-Risk Undifferentiated Pleomorphic Sarcoma
NCT07817095Undifferentiated Pleomorphic Sarcoma (UPS)
Tianjin Medical University Cancer Institute and Hospital
Phase 2
39
Tianjin
2026-09
Not yet open
Dual GIP/GLP-1 Receptor Agonist in Obese Women Before Frozen Embryo Transfer
NCT07811895Tirzepatide, Frozen Embryo Transfer, Obesity
RenJi Hospital
Not applicable
1,510
Shanghai
2026-09
Not yet open
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of HDM1005 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity Receiving Positive Airway Pressure (PAP) Therapy
NCT07794397Obstructive Sleep Apnea (OSA) and Obesity
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 3
200
Beijing
2026-09
Not yet open
A Trial of HRS-1780 in Participants With Uncontrolled Hypertension or Resistant Hypertension.
NCT07708441Uncontrolled or Resistant Hypertension
Shandong Suncadia Medicine Co., Ltd.
Phase 2/3
914
Chongqing, Shanghai
2026-09
Not yet open
A Study of BL-B01D1 Combination Therapy in Patients With Metastatic Castration-resistant Prostate Cancer
NCT07641855Castration-resistant Prostate Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2/3
180
Beijing, Shanghai
2026-09
Not yet open
A Study of BL-M08D1 in Patients With Recurrent or Metastatic Gynecological Malignancies and Other Solid Tumors
NCT07793825Gynecological Tumors, Solid Tumors
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1/2
90
Hangzhou
2026-09
Not yet open
Safety and Pharmacokinetics of HRS-1597 Tablets in Healthy and Obese Participants: A Phase 1 Study
NCT07808918Obese and Metabolic Disorders
Shandong Suncadia Medicine Co., Ltd.
Phase 1
78
Hefei
2026-09
Not yet open
Oliceridine Versus Sufentanil Analgesia for Postoperative Patients With Obstructive Sleep Apnea
NCT07753785Obstructive Sleep Apnea, Postoperative Analgesia, Oliceridine, Sufentanil
Peking University First Hospital
Observational
851
Beijing
2026-09
Not yet open
A Clinical Study of SHR-4595 Injection in Patients With Advanced Solid Tumors to Evaluate Safety, Tolerability and Pharmacokinetics
NCT07830199Solid Tumor
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1
208
Shenyang, Tianjin
2026-09
Not yet open
A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
NCT07668336Diabetes Mellitus, Type 2
Eli Lilly and Company
Phase 3
170
2026-09
Not yet open
A Phase I Study of HXN5003 in Healthy Participants and Patients With Moderate-to-Severe Atopic Dermatitis
NCT07801612Health Adult Subjects, Moderate-to-Severe Atopic Dermatitis
Helixon Biotechnology (Suzhou) Co., Ltd
Phase 1
68
Hangzhou
2026-09
Not yet open
Lorlatinib Plus Sacituzumab Tirumotecan With Peripheral ctDNA Guidance as First-Line Therapy for ALK Fusion-Positive NSCLC
NCT07750704ALK Positive Non-small Cell Lung Cancer
Guangdong Association of Clinical Trials
Phase 2
153
Guangzhou
2026-09
Not yet open
AI-Assisted Patient Support in mHSPC
NCT07804030Metastatic Prostate Cancer
Fudan University
Not applicable
160
Fuzhou, Shanghai, Kunming, Wenzhou
2026-09
Not yet open
A Study of BL-B01D1 Combined With Glecirasib in Patients With KRAS G12C-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT07827261Non-small Cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
36
Guangzhou
2026-09
Not yet open
A Clinical Trial of TQF3250 Capsules in Overweight/Obese Trial Participants With Poor Weight Control Through Simple Lifestyle Intervention
NCT07798284Overweight/Obesity
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1
80
Beijing, Guangzhou, Zhengzhou, Wuhan, Xianning, Jinan, Shanghai, Luzhou
2026-09
Not yet open
A Phase I, Single-Arm, Open-Label Clinical Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of CHT101 Injection in Subjects With Relapsed/Refractory T-Cell and B-Cell Hematological Malignancies
NCT07809126Hematological Malignancies
Nanjing Miracle Biotechnology Co., Ltd.
Phase 1
30
Nanchang
2026-09
Not yet open
Effectiveness of Artificial Intelligence-Assisted Colonoscopy for Adenoma Detection in Routine Clinical Practice : a Prospective Multicenter Randomized Trial
NCT07307547Colorectal Neoplasms, Colonic Polyp, Adenoma, Colorectal Cancer
Zhejiang University
Not applicable
3,300
Hangzhou
2026-09
Not yet open
ctDNA-MRD Monitoring After Neoadjuvant Therapy in Gastric Cancer With pCR or MPR
NCT07799649Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University
Observational
150
Nanjing
2026-09
Not yet open
Study of Oral HRS-5346 in Adult Patients With Elevated Lipoprotein(a) and High Risk of Cardiovascular Events
NCT07767513Lipoprotein Disorder
Shandong Suncadia Medicine Co., Ltd.
Phase 2
60
Chengdu
2026-09
Not yet open
Study of YKST02 in Adults With Relapsed or Refractory Multiple Myeloma
NCT07695740Relapsed or Refractory Multiple Myeloma (RRMM)
Excyte Biopharma Ltd
Phase 2
64
Beijing
2026-09
Not yet open
A Multicenter Real-World Study Evaluating the Efficacy and Safety of Shugan Jieyu Capsules in the Treatment of Depression
NCT07785284Outpatients or Inpatients With Depression
Peking University
Not applicable
400
Beijing
2026-09
Not yet open
A Clinical Study to Evaluate CHT101 Injection in Subjects With Relapsed/Refractory T-Cell and B-Cell Hematologic Malignancies
NCT07809139Hematological Malignancies
Nanjing Miracle Biotechnology Co., Ltd.
Phase 1
30
Nanchang
2026-09
Recruiting
Plantar Stimulation, Whole-Body Vibration, and Baduanjin for Muscle Activation
NCT07811674Flat Feet, Lower-Limb Muscle Activation, Neuromuscular Response
Nanfang Hospital, Southern Medical University
Not applicable
30
Guangzhou
2026-09
Not yet open
18F-S2P PET Imaging in the Evaluation of Large Artery Atherosclerosis
NCT07815860Large-Artery Atherosclerosis (Embolus/Thrombosis)
First Affiliated Hospital of Zhejiang University
Not applicable
200
Zhejiang
2026-09
Not yet open
A Study of GFH276 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors and Pancreatic Ductal Adenocarcinoma (PDAC) Harboring RAS Mutation
NCT07678593Advanced Solid Tumors Cancer, Pancreatic Ductal Adenocarcinoma, RAS Mutation
Genfleet Therapeutics (Shanghai) Inc.
Phase 1/2
222
Beijing, Guangzhou, Harbin, Zhengzhou, Wuhan, Shenyang, Xi'an, Jinan
2026-09
Not yet open
Efficacy and Safety of Hebenrun in Patients With Type 2 Diabetes
NCT07768280Type 2 Diabetes Mellitus
Jiangxi University of Traditional Chinese Medicine
Not applicable
110
Nanchang
2026-09
Not yet open
Evaluation of 611 in Chinese Children With Moderate to Severe Atopic Dermatitis(AD)
NCT07767253Dermatitis, Atopic
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Phase 3
246
Beijing, Guangzhou, Changsha, Hangzhou
2026-09
Not yet open
CoQ10 Effects on MDM Liver Fat Via FibroTouchI.
NCT07748130Mitochondrial Diabetes
The 95th Hospital of Putian๏ผŒPutian, Fujian, China
Not applicable
30
Putian
2026-09
Not yet open
Daridorexant for Sleep Disturbance in Adults With Liver Cirrhosis
NCT07830303Liver Cirrhosis, Sleep Disturbance, Hepatic Encephalopathy
Wang Fengmei
Phase 4
180
Tianjin
2026-09
Not yet open
A Phase II Study of SSGJ-612 Plus a HER2-Targeted ADC in HR-Positive, HER2-Low or HER2-Ultralow Expression Metastatic Breast Cancer
NCT07757230Metastatic Breast Cancer
Shenyang Sunshine Pharmaceutical Co., LTD.
Phase 2
87
Guangzhou
2026-09
Not yet open
Yiqi Fumai Lyophilized Injection for Chronic Heart Failure Caused by Coronary Heart Disease
NCT07803471Chronic Heart Failure, Heart Failure With Reduced Ejection Fraction (HFrEF), Coronary Heart Disease (CHD)
China Academy of Chinese Medical Sciences
Not applicable
100
Guangzhou, Zhengzhou, Jinan, Tianjin
2026-09
Not yet open
A Clinical Trial of TQF6422 Injection in Overweight or Obese Healthy Subjects.
NCT07794111Obesity / Overweight
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Phase 1
108
Shanghai
2026-09
Not yet open
Birelentinib Plus R-CHOP in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (TAI-SHAN19)
NCT07712588Diffuse Large B-Cell Lymphoma (DLBCL)
Dizal Pharmaceuticals
Phase 2/3
880
Chongqing, Harbin, Changsha, Jinan, Shanghai
2026-09
Not yet open
HEC-921 Injection as Monotherapy and in Combination With Antineoplastic Therapies in Patients With Advanced Malignant Solid Tumors
NCT07824934Advanced Malignant Solid Tumors
Sunshine Lake Pharma Co., Ltd.
Phase 1
110
Shanghai
2026-09
Not yet open
Phase Ib Study of Oral R01 Monotherapy in Advanced Solid Tumors
NCT07806500Squamous Cell Lung Cancer, Gastric Cancer, Esophageal Cancer
Beijing Anjianxi Bio-Medical Technology Co., Ltd.
Phase 1
18
Beijing
2026-09
Not yet open
AI-Assisted Chest CT Interpretation Across the Lung Cancer Care Continuum
NCT07829640Lung Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
15
Wuhan
2026-09
Not yet open
Video-Assisted Thoracoscopic Surgery Combined With Radiofrequency Ablation Versus VATS Alone for Multiple Primary Lung Cancer
NCT07819669Multiple Primary Lung Cancers
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not applicable
160
Taiyuan, Beijing, Shenzhen
2026-09
Not yet open
Phase 3 Study to Evaluate the Efficacy and Safety of Human Growth Hormone Injection (Sinotropin AQ) for the Treatment of Children With Idiopathic Short Stature
NCT07815626Idiopathic Short Stature (ISS)
Zhongshan Sansure Hygene Biomedicine Co., Ltd.
Phase 3
240
Hefei, Beijing, Xiamen, Guangzhou, Tangshan, Wuhan, Changsha, Nanjing
2026-09
Not yet open
Standardized MRI and Structured Reporting for Esophageal Squamous Cell Carcinoma
NCT07769658Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University
Observational
500
Guangzhou, Zhengzhou, Shanghai, Chengdu, Tianjin, Kunming
2026-09
Not yet open
Guided Laminectomy With Augmented Duroplasty for Acute Traumatic Spinal Cord Injury
NCT07733401Spinal Cord Injury, Acute Spinal Cord Injury (SCI)
Xuanwu Hospital, Beijing
Not applicable
80
Beijing, Guangzhou, Maoming, Cangzhou, Shijiazhuang, Chifeng, Dezhou, Jinan
2026-09
Not yet open
Sequential PD-1 Antibody and Pegylated Interferon Therapy for Nucleos(t)Ide Analogue-suppressed Chronic Hepatitis B
NCT07809165Chronic Hepatitis B
Beijing 302 Hospital
Not applicable
60
Jinan, Taiyuan, Xi'an
2026-09
Not yet open
A Phase II Clinical Study of SHR-7787 Injection Combined With SHR-1316 Injection in Patients With LS-SCLC
NCT07798947Limited-stage Small-cell Lung Cancer
Shanghai Hengrui Pharmaceutical Co., Ltd.
Phase 2
120
Jinan
2026-09
Not yet open
A Study of BL-M08D1 in Combination With Immunochemotherapy in Patients With Diffuse Large B-Cell Lymphoma
NCT07818499Diffuse Large B-Cell Lymphoma
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1/2
204
Guangzhou, Suzhou
2026-09
Not yet open
Unknown Time of Onset Stroke RePerfusIon Without Advanced Imaging
NCT07475949Acute Ischemic Stroke, Tenecteplase
First Affiliated Hospital of Guangxi Medical University
Phase 3
352
Nanning
2026-09
Not yet open
A Study to Evaluate the Effectiveness and Safety of Restylane Shaype in the Improvement of Jawline Definition
NCT07805512Jawline Definition
Galderma R&D
Not applicable
162
Beijing
2026-09
Recruiting
Drug-Drug Interaction Study of Befotertinib Capsules in Healthy Participants.
NCT07809815DDI (Drug-Drug Interaction)
Betta Pharmaceuticals Co., Ltd.
Phase 1
36
Hangzhou
2026-09
Not yet open
A Randomized, Double-Blind, Dose-Escalation, Placebo-Controlled Study of SHR-1179 Injection in Participants With Obesity
NCT07826364Body Weight Management
Guangdong Hengrui Pharmaceutical Co., Ltd
Phase 1
50
Shanghai
2026-09
Not yet open
ZG005 Plus Bevacizumab vs Sintilimab Plus Bevacizumab as First-Line Therapy for Advanced Hepatocellular
NCT07813572Hepatocellular Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 3
600
Nanjing
2026-09
Not yet open
An Open-Label, Multicenter, Phase IB/II Clinical Study of HRS-7172 in Combination With Antitumor Therapy in Participants With Solid Tumors
NCT07806058Pancreatic Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2
140
Shanghai
2026-09
Not yet open
Study of SGC001 Injection for Predicted Severe Acute Pancreatitis to Assess Safety, Tolerability and Preliminary Efficacy
NCT07803965Acute Pancreatitis
Beijing Sungen Biomedical Technology Co., Ltd
Phase 2
129
Chengdu, Guizhou, Hangzhou, Hefei, Luoyang, Nanchang, Nanjing, Ningbo
2026-09
Not yet open
A Phase I Study of GenSci148 Intravitreal Injection for Neovascular Age-related Macular Degeneration, Diabetic Macular Edema and Retinal Vein Occlusion
NCT07817615Neovascular Age-related Macular Degeneration (nAMD), Diabetic Macular Edema (DME), Retinal Vein Occlusion (RVO)
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
60
Shanghai
2026-09
Recruiting
Pharmacokinetic Study of Vorolanib Tablets in Trial Participants With Hepatic Impairment
NCT07809802Hepatic Impairment (HI)
Betta Pharmaceuticals Co., Ltd.
Phase 1
36
Changchun
2026-09
Not yet open
Spinal Cord Stimulation Combined With Motor Imagery Brain-Computer Interface for Chronic Post-Stroke Upper Limb Motor Dysfunction
NCT07686822Chronic Stroke
Zhejiang Provincial People's Hospital
Not applicable
66
Hangzhou
2026-09
Not yet open
Clinical Study of CHT105 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases
NCT07811622Immune Thrombocytopenia (ITP)
Nanjing Miracle Biotechnology Co., Ltd.
Not applicable
24
Nanchang
2026-09
Not yet open
Percutaneous Pulsed Electric Field Ablation for Early-Stage NSCLC and Lung Oligometastases: A Safety and Efficacy Study
NCT07799194Lung Cancer (NSCLC)
Energenx Medical LTD.
Not applicable
10
Guangzhou
2026-09
Not yet open
Safety and Diagnostic Performance of 111In-TJD-31 SPECT Imaging in Patients With Solid Tumors
NCT07815951Solid Tumors, Carcinoma, Ovarian Neoplasms, Endometrial Neoplasms Malignant
Yong He
Phase 1
8
Wuhan
2026-09
Not yet open
A Study of BL-M08D1 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma and Other Solid Tumors
NCT07818486Nasopharyngeal Carcinoma (NPC), Solid Tumors
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1/2
30
Chongqing, Guangzhou
2026-09
Not yet open
GLP-1 Agonists for Prevention of Recurrent Hypertriglyceridemic Acute Pancreatitis
NCT07617155Hypertriglyceridemia Induced Acute Pancreatitis, Recurrent Acute Pancreatitis, Pancreatitis Relapsing, Hypertriglyceridemia
Peking Union Medical College Hospital
Phase 4
396
Beijing
2026-09
Not yet open
The Study to Evaluate the Plaque Control and Anti-Gingivitis Efficacy of a Toothpaste in Chinese Population
NCT07816406Dental Plaque, Gingivitis
HALEON
Not applicable
120
Shanghai
2026-09
Not yet open
Study of HXN6005 in Healthy Participants and Patients With Moderate-to-Severe Atopic Dermatitis
NCT07782476Health Adult Subjects, Atopic Dermatitis (AD)
Helixon Biotechnology (Suzhou) Co., Ltd
Phase 1/2
67
Hangzhou
2026-09
Recruiting
A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
NCT07680764Locally Advanced Non-Small Cell Lung Cancer (NSCLC), Metastatic Non-Small Cell Lung Cancer (NSCLC)
Bristol-Myers Squibb
Phase 2
160
Beijing, Fuzhou, Wuhan, Nanjing, Shanghai, Chengdu, Hangzhou
2026-08-31
Not yet open
A Phase 3 Study of Efficacy and Safety of AK3280 in Patients With Idiopathic Pulmonary Fibrosis
NCT07719023Idiopathic Pulmonary Fibrosis (IPF)
Shanghai Ark Biopharmaceutical Co., Ltd.
Phase 3
263
Beijing
2026-08-31
Not yet open
Retlirafusp Alfa Combined With Famitinib, Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Unresectable Pancreatic Cancer
NCT07814859Pancreatic Cancer
The First Affiliated Hospital of Zhengzhou University
Phase 2
88
Zhengzhou
2026-08-31
Not yet open
CEEEC-II: A 12-Week Physical and Cognitive Enrichment Extension Study in Older Stroke Survivors With Multimorbidity
NCT07778771Stroke, Hypertension, Type 2 Diabetes Mellitus (T2DM), Multimorbidity
Duke Kunshan University
Not applicable
365
Kunshan
2026-08-31
Not yet open
Evaluate the Efficacy and Safety of VV913 Capsules in the Treatment of PE
NCT07722780Premature Ejaculation
Vigonvita Life Sciences
Phase 2
500
Beijing
2026-08-31
Not yet open
Digital Rehabilitation With Wearable Monitors for Sequential Lung Cancer Resection
NCT07797075Non-Small Cell Lung Cancer (NSCLC), Rehabilitation, Thoracic Surgery
West China Hospital
Not applicable
222
Chengdu
2026-08-31
Recruiting
A Study Comparing BL-M07D1 With DS-8201 in Patients With HR-Positive, HER2-Low Expressing Recurrent/Metastatic Breast Cancer
NCT07678957Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
120
Beijing
2026-08-31
Not yet open
Early EIT-Guided PEEP Titration on Pulmonary Physiology in Patients With Moderate-to-Severe ARDS Undergoing Prone Positioning (EIT-PEEP-PRONE)
NCT07793565Acute Respiratory Distress Syndrome (ARDS)
XIE MIN
Not applicable
40
Wuhan
2026-08-31
Rows per page Showing 501–600 of 19052
Previous 4 5 6 7 8 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china?page=6

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.